NIFTY NINE IN NINETY NINE PLUS ONE Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : NIFTY NINE IN NINETY NINE PLUS ONE

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (393)	2/11/1999 8:58:00 AM
From: Scott H. Davis	of 613

(FYI) Axys Pharmaceuticals Advances Clinical Development of APC 2059 in Both Psoriasis and Acute Inflammatory Bowel Disease. Looks like some possible competition for ISIP down the road. biz.yahoo.com On ENMD, a secretary where I used to work has been an incredibly succesfull tech stock picker. She bought ENMD on the WSJ article, had never bought a biotech before, did not know anything about the clinical trials process, or that others had meds in the same class further along. Wonder how likely she is to buy another biotech. Scott

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next